Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2C9 | P11712 | 11/20 | 0.60 |
| ▸ | CYP3A4 | P08684 | 11/20 | 0.60 |
| ▸ | CYP2C19 | P33261 | 8/20 | 0.60 |
| ▸ | CYP2D6 | P10635 | 5/20 | 0.60 |
| ▸ | TSHR | P16473 | 4/20 | 0.60 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.60 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.58 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.58 |
| ▸ | CHKA | P35790 | 1/20 | 0.54 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.53 |
| ▸ | MEN1 | O00255 | 1/20 | 0.53 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.53 |
| ▸ | USP2 | O75604 | 1/20 | 0.49 |
| ▸ | CASP1 | P29466 | 1/20 | 0.49 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30847879 | 0.91 | CYP2C9 (0.62) | CYP2C9CYP3A4CYP2C19CYP2D6TSHR | |
| SCHEMBL25506005 | 0.82 | CYP3A4 (0.69) | CYP2C9CYP3A4CYP2C19CYP2D6TSHR | |
| SCHEMBL11947914 | 0.81 | CYP3A4 (0.67) | CYP2C9CYP3A4CYP2C19CYP2D6TSHR | |
| SCHEMBL14996512 | 0.79 | CYP3A4 (0.64) | CYP2C9CYP3A4CYP2C19CYP2D6TSHR | |
| SCHEMBL14996494 | 0.78 | CYP3A4 (0.65) | CYP2C9CYP3A4CYP2C19CYP2D6TSHR | |
| SCHEMBL14996490 | 0.78 | CYP2C9 (0.63) | CYP2C9CYP3A4CYP2C19CYP2D6TSHR | |
| SCHEMBL24850914 | 0.78 | CYP2C9 (0.53) | CYP2C9CYP3A4CYP2C19CYP2D6TSHR | |
| SCHEMBL21667712 | 0.78 | CYP2C9 (0.54) | CYP2C9CYP3A4CYP2C19CYP2D6TSHR | |
| SCHEMBL25876537 | 0.76 | CYP2C9 (0.61) | CYP2C9CYP3A4CYP2C19CYP2D6TSHR | |
| SCHEMBL13167762 | 0.76 | CYP3A4 (0.59) | CYP2C9CYP3A4CYP2C19CYP2D6TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230150980-A1 | COLLAGEN 1 TRANSLATION INHIBITORS AND METHODS OF USE THEREOF | ANIMA BIOTECH INC. (US) | 2023-05-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230150980-A1 | COLLAGEN 1 TRANSLATION INHIBITORS AND METHODS OF USE THEREOF | COL1A1, COL2A1, COL14A1 | CYP2C9 3658/4885CYP3A4 4190/4885CYP2C19 3762/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.